Safety of poly-L-lactic acid (New-Fill(®)) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients

BACKGROUND: Facial lipoatrophy is a frequently reported condition associated with use of antiretroviral (ARV) drugs. Poly-L-lactic acid (PLLA) acid has been used to correct facial lipoatrophy in people with HIV since 2004 both in Europe and the United States. The objective of this study was to estab...

Descripción completa

Detalles Bibliográficos
Autores principales: Duracinsky, Martin, Leclercq, Pascale, Herrmann, Susan, Christen, Marie-Odile, Dolivo, Marc, Goujard, Cécile, Chassany, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160543/
https://www.ncbi.nlm.nih.gov/pubmed/25178390
http://dx.doi.org/10.1186/1471-2334-14-474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160543/
https://www.ncbi.nlm.nih.gov/pubmed/25178390
http://dx.doi.org/10.1186/1471-2334-14-474

Ejemplares similares